Regulus Therapeutics Inc Stock Nasdaq
Equities
US75915K1016
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 145M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -46M | EV / Sales 2024 * | - |
Net cash position 2024 * | 94.2M | Net cash position 2025 * | 50.8M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.37
x | P/E ratio 2025 * |
-3.64
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.99% |
Latest transcript on Regulus Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 16-01-03 |
Preston Klassen
PSD | President | 55 | 23-06-21 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 19-08-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 17-05-31 |
David Baltimore
BRD | Director/Board Member | 86 | 08-12-31 |
Director/Board Member | 75 | 13-03-31 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.11% | 22.2B | |
-16.53% | 21.23B | |
-8.79% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |